Bruno Galli

The <scp>BACE</scp> ‐1 inhibitor <scp>CNP</scp> 520 for prevention trials in Alzheimer's disease

Ulf Neumann, Mike Ufer, Laura H. Jacobson et al. · EMBO Molecular Medicine · 2018 · 167 citations · Full text

Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state

Fanny De Jaeghere, Éric Allémann, F. Kubel et al. · Journal of Controlled Release · 2000 · 92 citations

Oral Bioavailability, Antiviral Compound, Ph-sensitive Particles +9

Transformation of acidic poorly water soluble drugs into ionic liquids

Anja Balk, Johannes Wiest, Toni Widmer et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2015 · 86 citations

Ion Exchange, Ionic Liquids, Medicine +8

Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to Mice

Jean-Christophe Leroux, Robert Cozens, Johannes Roesel et al. · Journal of Pharmaceutical Sciences · 1995 · 74 citations

Enteric Nanoparticles, Nanomedicine, Engineering +10

High protein yogurt with addition of Lactobacillus helveticus: Peptide profile and angiotensin-converting enzyme ACE-inhibitory activity

Flávia Giacometti Cavalheiro, Débora Parra Baptista, Bruno Galli et al. · Food Chemistry · 2020 · 69 citations · Full text